| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/30/2023 | 3.9% | UBS | $1.75 → $2 | Maintains | Neutral |
| 03/09/2023 | — | B of A Securities | Downgrades | Outperform → Market Perform | |
| 03/09/2023 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 12/16/2022 | -9.09% | Morgan Stanley | $2.25 → $1.75 | Maintains | Equal-Weight |
| 11/21/2022 | 29.87% | Credit Suisse | $3.25 → $2.5 | Maintains | Outperform |
| 11/09/2022 | -35.06% | Citigroup | $1.5 → $1.25 | Maintains | Sell |
| 10/17/2022 | -48.05% | Barclays | $2 → $1 | Maintains | Equal-Weight |
| 10/04/2022 | -22.08% | Goldman Sachs | $1.7 → $1.5 | Maintains | Neutral |
| 07/13/2022 | -11.69% | Goldman Sachs | $1.5 → $1.7 | Maintains | Neutral |
| 07/11/2022 | 3.9% | Barclays | $3 → $2 | Maintains | Equal-Weight |
| 06/28/2022 | 55.84% | Piper Sandler | $3.5 → $3 | Maintains | Neutral |
| 05/12/2022 | 19.48% | Goldman Sachs | $3.9 → $2.3 | Maintains | Neutral |
| 05/11/2022 | 16.88% | Morgan Stanley | $4 → $2.25 | Maintains | Equal-Weight |
| 05/11/2022 | 3.9% | Citigroup | $5 → $2 | Downgrades | Neutral → Sell |
| 05/11/2022 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 05/11/2022 | 81.82% | Piper Sandler | $6 → $3.5 | Downgrades | Overweight → Neutral |
| 04/12/2022 | 159.74% | Barclays | $6 → $5 | Maintains | Equal-Weight |
| 04/05/2022 | 211.69% | Piper Sandler | $7 → $6 | Maintains | Overweight |
| 04/04/2022 | 102.6% | Goldman Sachs | $4.8 → $3.9 | Maintains | Neutral |
| 02/17/2022 | 263.64% | JMP Securities | $12 → $7 | Maintains | Market Outperform |
| 02/02/2022 | 159.74% | Citigroup | $12 → $5 | Downgrades | Buy → Neutral |
| 02/02/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 01/10/2022 | 211.69% | Barclays | $10 → $6 | Maintains | Equal-Weight |
| 01/05/2022 | — | Piper Sandler | Upgrades | Neutral → Overweight | |
| 11/02/2021 | 289.61% | Morgan Stanley | $7 → $7.5 | Maintains | Equal-Weight |
| 11/02/2021 | 575.32% | Credit Suisse | $15 → $13 | Maintains | Outperform |
| 11/02/2021 | 419.48% | Raymond James | $11 → $10 | Maintains | Outperform |
| 10/11/2021 | 419.48% | Barclays | $11 → $10 | Maintains | Equal-Weight |
| 08/18/2021 | 523.38% | JMP Securities | $21 → $12 | Maintains | Market Outperform |
| 08/04/2021 | 679.22% | Credit Suisse | $18 → $15 | Maintains | Outperform |
| 08/04/2021 | 419.48% | Morgan Stanley | $14 → $10 | Maintains | Equal-Weight |
| 08/04/2021 | 471.43% | Raymond James | $22 → $11 | Maintains | Outperform |
| 07/21/2021 | 575.32% | B of A Securities | $21 → $13 | Downgrades | Buy → Underperform |
| 07/09/2021 | 679.22% | Barclays | $20 → $15 | Maintains | Equal-Weight |
| 05/28/2021 | 627.27% | Morgan Stanley | $21 → $14 | Maintains | Equal-Weight |
| 05/04/2021 | 1042.86% | Raymond James | $23 → $22 | Maintains | Outperform |
| 04/21/2021 | 990.91% | Barclays | $25 → $21 | Downgrades | Overweight → Equal-Weight |
| 03/10/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 03/09/2021 | 1198.7% | Citigroup | → $25 | Initiates Coverage On | → Buy |
| 03/09/2021 | 1614.29% | Jefferies | → $33 | Initiates Coverage On | → Buy |
| 03/09/2021 | 938.96% | UBS | → $20 | Initiates Coverage On | → Neutral |
| 03/09/2021 | 1198.7% | JMP Securities | → $25 | Initiates Coverage On | → Outperform |
| 03/09/2021 | 1198.7% | Credit Suisse | → $25 | Initiates Coverage On | → Outperform |
| 03/09/2021 | 938.96% | Piper Sandler | → $20 | Initiates Coverage On | → Neutral |
| 03/09/2021 | 990.91% | Morgan Stanley | → $21 | Initiates Coverage On | → Equal-Weight |
| 03/09/2021 | 1198.7% | Barclays | → $25 | Initiates Coverage On | → Overweight |
| 03/08/2021 | 1094.81% | Raymond James | → $23 | Initiates Coverage On | → Outperform |
| 03/08/2021 | 1042.86% | Goldman Sachs | → $22 | Initiates Coverage On | → Neutral |
What is the target price for loanDepot (LDI)?
The latest price target for loanDepot (NYSE: LDI) was reported by UBS on August 30, 2023. The analyst firm set a price target for $2.00 expecting LDI to rise to within 12 months (a possible 3.90% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for loanDepot (LDI)?
The latest analyst rating for loanDepot (NYSE: LDI) was provided by UBS, and loanDepot maintained their neutral rating.
When is the next analyst rating going to be posted or updated for loanDepot (LDI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of loanDepot, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for loanDepot was filed on August 30, 2023 so you should expect the next rating to be made available sometime around August 30, 2024.
Is the Analyst Rating loanDepot (LDI) correct?
While ratings are subjective and will change, the latest loanDepot (LDI) rating was a maintained with a price target of $1.75 to $2.00. The current price loanDepot (LDI) is trading at is $1.93, which is within the analyst's predicted range.